Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?

摘要

Although multiple therapeutic options are available for type 2 diabetes mellitus (T2DM), a large number of patients are unable to achieve, or maintain, glycemic control. A critical need clearly exists for new therapeutic approaches to T2DM.